Literature DB >> 15222652

Metabolic syndrome: time for action.

Darwin Deen1.   

Abstract

The constellation of dyslipidemia (hypertriglyceridemia and low levels of high-density lipoprotein cholesterol), elevated blood pressure, impaired glucose tolerance, and central obesity is identified now as metabolic syndrome, also called syndrome X. Soon, metabolic syndrome will overtake cigarette smoking as the number one risk factor for heart disease among the U.S. population. The National Cholesterol Education Program-Adult Treatment Panel III has identified metabolic syndrome as an indication for vigorous lifestyle intervention. Effective interventions include diet, exercise, and judicious use of pharmacologic agents to address specific risk factors. Weight loss significantly improves all aspects of metabolic syndrome. Increasing physical activity and decreasing caloric intake by reducing portion sizes will improve metabolic syndrome abnormalities, even in the absence of weight loss. Specific dietary changes that are appropriate for addressing different aspects of the syndrome include reducing saturated fat intake to lower insulin resistance, reducing sodium intake to lower blood pressure, and reducing high-glycemic-index carbohydrate intake to lower triglyceride levels. A diet that includes more fruits, vegetables, whole grains, monounsaturated fats, and low-fat dairy products will benefit most patients with metabolic syndrome. Family physicians can be more effective in helping patients to change their lifestyle behaviors by assessing each patient for the presence of specific risk factors, clearly communicating these risk factors to patients, identifying appropriate interventions to address specific risks, and assisting patients in identifying barriers to behavior change.

Entities:  

Mesh:

Year:  2004        PMID: 15222652

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  20 in total

1.  Gender and quality of life after cerebral stroke.

Authors:  Amra Zalihić; Vedran Markotić; Dino Zalihić; Mirela Mabić
Journal:  Bosn J Basic Med Sci       Date:  2010-05       Impact factor: 3.363

2.  The relationship between low bone mass and metabolic syndrome in Korean women.

Authors:  D-K Hwang; H-J Choi
Journal:  Osteoporos Int       Date:  2009-06-30       Impact factor: 4.507

3.  Why nutrition matters in healthcare outcomes.

Authors:  Jacqueline Gamble
Journal:  Ochsner J       Date:  2008

Review 4.  The biological actions of dehydroepiandrosterone involves multiple receptors.

Authors:  Stephanie J Webb; Thomas E Geoghegan; Russell A Prough; Kristy K Michael Miller
Journal:  Drug Metab Rev       Date:  2006       Impact factor: 4.518

5.  Overweight and obesity among adults in Serbia: results from the National Health Survey.

Authors:  Vera Grujić; N Dragnić; I Radić; S Harhaji; S Susnjević
Journal:  Eat Weight Disord       Date:  2010 Mar-Jun       Impact factor: 4.652

6.  Self-Reported Adherence among Individuals at High Risk of Metabolic Syndrome: Effect of Knowledge and Attitude.

Authors:  Eman A Alefishat; Rana K Abu Farha; Mutaz M Al-Debei
Journal:  Med Princ Pract       Date:  2016-11-03       Impact factor: 1.927

7.  Case finding for hypertension in young adult patients attending a missionary hospital in Nigeria.

Authors:  R I Ekore; I O Ajayi; A Arije
Journal:  Afr Health Sci       Date:  2009-09       Impact factor: 0.927

8.  A Case Of Metabolic Syndrome.

Authors:  Rabia Khatoon; A R Sinnathuray
Journal:  Malays Fam Physician       Date:  2006-08-31

9.  Associations between the metabolic syndrome and bone health in older men and women: the Rancho Bernardo Study.

Authors:  D von Muhlen; S Safii; S K Jassal; J Svartberg; E Barrett-Connor
Journal:  Osteoporos Int       Date:  2007-05-11       Impact factor: 4.507

10.  Anti-obesity and anti-diabetic effects of a standardized potato extract in ob/ob mice.

Authors:  Sae Kwang Ku; Soo Hyun Sung; Jai Jun Choung; Jae-Suk Choi; Yong Kook Shin; Joo Wan Kim
Journal:  Exp Ther Med       Date:  2016-04-14       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.